Pseudotumor cerebri historical perspective: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Pseudotumor cerebri}} {{CMG}}; {{AE}} ==Overview== ==Historical Perspective== ===Discovery=== *[Disease name] was first discovered by [name of scientist], a [...")
 
No edit summary
Line 7: Line 7:


==Historical Perspective==
==Historical Perspective==
 
Nonne in 1904 named this disease “pseudotumor cerebri”(1) and Foley named it “benign intracranial hypertension” in 1955.(2) They both described it as increased intracranial pressure with no brain tumor. Buchheit et al  suggested that the terms “benign” and “pseudtumor” are not appropriate and introduced the name “Idiopathic intracranial hypertesion”.(3) The first patient with idiopathic intracranial hypertension was introduced by Quincke in 1893. He described 10 cases with headache, papilledema and increased CSF pressure with normal cell count, glucose and protein.(12) For the first time, Walter Dandy described diagnostic criteria for idiopathic intracranial hypertension in 1937 and then modified by in 1985 and Friedman and Jacobson i 2002.(19_20_21)
===Discovery===
*[Disease name] was first discovered by [name of scientist], a [nationality + occupation], in [year]/during/following [event].
 
*The association between [important risk factor/cause] and [disease name] was made in/during [year/event].
*In [year], [scientist] was the first to discover the association between [risk factor] and the development of [disease name].
*In [year], [gene] mutations were first implicated in the pathogenesis of [disease name].
 
==Outbreaks==
There have been several outbreaks of [disease name], which are summarized below:
 
==Landmark Events in the Development of Treatment Strategies==
In [year], [diagnostic test/therapy] was developed by [scientist] to treat/diagnose [disease name].
 
==Impact on Cultural History==
 
==Famous Cases==
The following are a few famous cases of [[disease name]]:


==References==
==References==

Revision as of 15:16, 31 July 2018

Pseudotumor cerebri Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating pseudotumor cerebri from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pseudotumor cerebri historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pseudotumor cerebri historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pseudotumor cerebri historical perspective

CDC on Pseudotumor cerebri historical perspective

Pseudotumor cerebri historical perspective in the news

Blogs on Pseudotumor cerebri historical perspective

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Pseudotumor cerebri historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Historical Perspective

Nonne in 1904 named this disease “pseudotumor cerebri”(1) and Foley named it “benign intracranial hypertension” in 1955.(2) They both described it as increased intracranial pressure with no brain tumor. Buchheit et al  suggested that the terms “benign” and “pseudtumor” are not appropriate and introduced the name “Idiopathic intracranial hypertesion”.(3) The first patient with idiopathic intracranial hypertension was introduced by Quincke in 1893. He described 10 cases with headache, papilledema and increased CSF pressure with normal cell count, glucose and protein.(12) For the first time, Walter Dandy described diagnostic criteria for idiopathic intracranial hypertension in 1937 and then modified by in 1985 and Friedman and Jacobson i 2002.(19_20_21)

References

Template:WH Template:WS